AMEH:NSD-Apollo Medical Holdings, Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 26.86

Change

+0.42 (+1.59)%

Market Cap

USD 1.17B

Volume

0.05M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Company Website : http://www.apollomed.net

Address : 1668 South Garfield Avenue, Alhambra, CA, United States, 91801

Employees : 630

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.48

52 Week High : 28.33

Short Ratio : 5.38

52 Week Low : 13.80

Shorted Shares : 389,072

200 Day Moving Average : 21.57

Shorted Shares Previous Month : 370,088

50 Day Moving Average : 26.49

Shares Held By Insiders : 382.5%

Short Percentage : 1.00%

Shares Held by Institutions : 9.890000000000001%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-21 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys, Inc

+4.02 (+1.43%)

 USD9.23B 50.91 32.85
LHCG LHC Group, Inc

+4.77 (+2.31%)

 USD6.51B 57.88 26.96
ACHC Acadia Healthcare Company, Inc

+1.85 (+3.05%)

 USD5.43B 47.80 19.03
ENSG The Ensign Group, Inc

+1.90 (+2.17%)

 USD4.82B 28.64 20.96
SGRY Surgery Partners, Inc

+3.65 (+8.57%)

 USD2.56B 63.00 19.94
PRSC The Providence Service Corpora..

N/A

 USD2.21B 74.23 15.08
HCSG Healthcare Services Group, Inc

+3.69 (+13.21%)

 USD2.09B 21.16 12.96
ADUS Addus HomeCare Corporation

+2.35 (+2.22%)

 USD1.68B 50.91 31.34
PNTG The Pennant Group, Inc

+1.19 (+2.96%)

 USD1.17B 188.80 64.15
TVTY Tivity Health, Inc

-0.02 (-0.08%)

 USD1.17B 8.78 9.45

ETFs Containing AMEH

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 47.02% 78% C+ 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.02% 78% C+ 89% B+
Trailing 12 Months  
Capital Gain 97.65% 61% D- 69% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.65% 61% D- 69% D+
Trailing 5 Years  
Capital Gain 399.26% 64% D 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 399.26% 64% D 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 49.00% 78% C+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.00% 78% C+ 86% B
Risk Return Profile  
Volatility (Standard Deviation) 71.45% 39% F 22% F
Risk Adjusted Return 68.58% 67% D+ 83% B
Market Capitalization 1.17B 53% F 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.18 79% C+ 40% F
Price/Book Ratio 3.61 68% D+ 45% F
Price / Cash Flow Ratio 25.30 16% F 18% F
EV/EBITDA 5.79 93% A 84% B
Management Effectiveness  
Return on Equity 30.35% 89% B+ 95% A
Return on Invested Capital 4.85% 42% F 66% D
Return on Assets 6.51% 84% B 89% B+
Debt to Equity Ratio 69.59% 38% F 31% F
Technical Ratios  
Short Ratio 5.38 22% F 17% F
Short Percent 1.86% 81% B- 67% D+
Beta 0.48 65% D 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.